AstraZeneca Pharma India Limited announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was INR 2,186.897 million compared to INR 1,312.983 million a year ago. Net income was INR 290.918 million compared to net loss of INR 103.522 million a year ago. Basic earnings per share was INR 11.64 compared to basic loss per share of INR 4.14 a year ago. For the nine months, total revenue was INR 5,482.646 million compared to INR 4,311.721 million a year ago. Net income was INR 446.165 million compared to INR 226.937 million a year ago. Basic earnings per share was INR 17.85 compared to INR 9.08 a year ago.